Ronald Harold Wilfred Cooper's most recent trade in C4 Therapeutics Inc was a trade of 35,500 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 18, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| C4 Therapeutics Inc | Ronald Harold Wilfred Cooper | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2025 | 35,500 | 35,500 | - | - | Stock Option (Right to Buy) | |
| Generation Bio Co | Ronald Harold Wilfred Cooper | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2025 | 30,000 | 30,000 | - | - | Stock Option (right to buy) | |
| enGene Holdings Inc | Ronald Harold Wilfred Cooper | Director, CEO & President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2025 | 850,000 | 850,000 | - | - | Stock Option (Right to Buy) |